Bronwyn Brophy Takes the Reins at Vitrolife AB – Get Ready for a New Era!

Bronwyn Brophy, an Irish national, possesses an impressive resume of leadership positions in some of the world’s most prominent Life Science and Medtech organizations, such as Thermo Fisher Scientific, Medtronic, and Johnson & Johnson. Most recently, as the head of Thermo Fischer’s Immunodiagnostics Division, Bronwyn Brophy was responsible for the organization’s global operations. Prior to this, she served as President of the EMEA region.

On 1 August 2023, Bronwyn Brophy will be joining the company, marking the latest addition to the team.

The board of directors has announced that Thomas Axelsson will be stepping down from his position as CEO on 31 March 2023, after which Jón Sigurdsson will take over as interim CEO until Bronwyn Brophy begins her appointment. In anticipation of this change, current board member Henrik Blomquist has been appointed as the new chairman of the board until the annual general meeting on 27 April 2023.

Jón Sigurdsson, Chairman of the Board, expressed his delight in appointing Bronwyn Brophy as the new CEO of Vitrolife. He highlighted her impressive record in developing businesses and her invaluable international experience, while also thanking Thomas Axelsson for his outstanding work and collaboration.

I am beyond thrilled to accept the appointment as the new CEO of Vitrolife. I am confident that, with the help of our committed distributors and global partners, the company will achieve great growth and reach new heights in the future.

Leave a Comment